Skip to main content

Tariffs may permanently raise medical goods costs – NBER study

Research also finds that trade barriers can worsen domestic supply shortages

medicine

US tariffs may permanently increase the costs of medical goods in the country, according to research published this month by the National Bureau of Economic Research.

The report’s authors – Manho Kang, Xiangtao Meng, Katheryn Russ and James Waters – say the higher costs of production in wealthier economies, such as the US, could inhibit medical supplies companies from relocating there. Suppliers might only be able to succeed in such markets “under conditions that permanently increase costs of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@centralbanking.com or view our subscription options here: subscriptions.centralbanking.com/subscribe

You are currently unable to copy this content. Please contact info@centralbanking.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Central Banking? View our subscription options

Register for Central Banking

All fields are mandatory unless otherwise highlighted

Show password
Hide password

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Central Banking account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account

.